Alibaba Health Information Technology Limited (“Alibaba Health”) will convene its 2026 Annual General Meeting (AGM) at FlyZoo Hotel, Hangzhou, on 7 August 2026 at 11:00 a.m.

Key items for shareholder approval:

1. Financial Statements • Shareholders will vote to adopt the audited consolidated results and directors’ and auditor’s reports for the fiscal year ended 31 March 2026.

2. Dividend Proposals (conditional) • Final dividend: RMB0.0595 per share, totaling approximately RMB0.96 billion. • Special dividend: RMB0.1352 per share, totaling approximately RMB2.18 billion. • Both payouts depend on the passing of a special resolution to reduce the share-premium account (see item 10).

3. Board & Auditor Matters • Re-election of four directors: Executive Director Sheng Mengyue; and Independent Non-executive Directors Huang Yi Fei (Vanessa), Shao Rong and Wu May Yihong. • Authorisation for the board to set directors’ remuneration. • Re-appointment of Ernst & Young as external auditor with board-determined fees.

4. Share Issuance & Buy-back Mandates • General mandate allowing directors to issue new shares up to 20% of issued share capital (excluding treasury shares). • Share-repurchase mandate of up to 10% of issued shares. • An extension mandate permits the board to add repurchased shares back to the issuance limit.

5. Capital Management • Special resolution seeks to reduce the share-premium account by RMB10.00 billion, from RMB51.69 billion to RMB41.69 billion. The credited amount will move to the contributed surplus account, enabling payment of the proposed dividends and other permissible uses. • Proposed amendments to the company’s bye-laws will also be tabled for shareholder approval.

Key Dates • Record date for AGM voting rights: 3 August 2026 (4:30 p.m. HK time, transfer cut-off). • Record date for dividend distribution: 13 August 2026.

The resolutions will be decided by poll, with results released on the websites of the Hong Kong Stock Exchange and Alibaba Health.